about pic
HomeSite MapContact Us
About Us: Team
Benjamin Soffer
ITTN - Co. Chairman of the Board.
Benjamin Soffer joined the Technion as CEO of T3 - Technion Technology Transfer office in 2005. As part of his duties at T3, Mr. Soffer is responsible for the establishment of startup companies and the commercialization of technologies arising from the Technion research. His Experience spans over 20 years in the areas of investment, industry and government in Israel, Europe, and the United States. In addition, Mr. Soffer serves as CEO of AMIT, a Technion hub for biomedical innovation; Chairman of T-Factor, the Technion engineering accelerator and , and Chairman of the ITTN – The Israeli Technology Transfer Organization. In addition Mr. Soffer serves on the boards of directors of numerous high growth companies. Prior to his position at the Technion, Mr. Soffer served as managing director of TopNotch Capital - and was as an investment advisor at Highbridge Capital. Between 1999 and 2003 he served as Israel's Economic attaché in Boston. There, Mr. Soffer was responsible for enhancing economic and business relations between Israel and the US Northeast region through private equity investments, joint ventures and trade. Prior to his tenure in Boston, Mr. Soffer served as special advisor to Dr. Orna Berry, Israel's chief scientist at the Ministry of Industry and Trade, where played a pivotal role in the initiation and implementation of innovative R&D programs. A certified lawyer in Israel and in the state of New York, Mr. Soffer has interned at Israel's Supreme Court and studied law at Tel Aviv University and at Ludwig Maximilian University in Munich. Additionally, he studied economics and business administration at Bar - Ilan University.
Yaacov  Michlin
ITTN – Director
Yaacov Michlin joined Yissum in 2009 and serves as Yissum's President and Chief Executive Officer. Mr. Michlin has been leading and assisting pharmaceutical, hi-tech and biomedical companies (including Teva, Bioline, CBI and Brainsway) in various technology commercialization deals, licensing agreements, capital raising, mergers and acquisitions and joint venture collaborations. Mr. Michlin was involved in the foundation and strategic guidance of a few companies and ventures. Prior to joining Yissum Mr. Michlin was a partner at Tulchinsky Stern & Co. Law Offices. He holds a Bachelor of Law and Economics, cum laude, and a Master of Law degree, both from Bar-Ilan University, Israel, and an MBA, cum laude, from the Technion Israel Institute of Technology, Israel.
Orit Shaked
ITTN - Director
Dr Shaked is the CEO of Biorap Technologies – the technology transfer unit of the Rappaport Family Institute for Research in the Medical Sciences. Dr Shaked is responsible for providing Rappaport Institute scientists with assistance in business development, strategic alliance development, identification of investors, establishment of startups, and other areas associated with commercialization of medical technologies. In addition, Biorap Technologies is responsible for managing the Genomic Core Facility which provides top tier genomic technologies to universities, hospitals and biopharma companies.
Until 2010 Dr. Orit Shaked was the Chief Technology Officer and Business Development at Meytav Technological Incubator. Prior to joining Meytav, Dr. Shaked served as the Director of Product ID and Portfolio management at Teva Pharmaceuticals, specializing in Biosimilar and Hospital franchises (Autoimmune diseases, Oncology, Endocrinology and Wound healing). She was responsible for project analysis, market opportunities evaluation and launch of the first Bio-similar product. Dr. Shaked was also the Managing Director of UBT Medical. She also held several research and development and business development positions in bio start-ups. Dr. Shaked is a Director of ITTN (Israel Tech Transfer Organization). And Turboseal Ltd. She holds a Ph.D. in Medical Sciences and an M.B.A. from the Technion – Israel institute of Technology.
Tamir  Huberman
ITTN - Director of IT
Tamir Huberman joined Yissum in 2004, he is VP Business Development in the field of Computer Science and IT Director. Tamir has developed the TTM, an IT system that is used by most of the TTO's in Israel.

In addition, he is also the IT Director at ITTN; the Israeli Technology Transfer Organization, a Director at InnerEye and Observer at BriefCam.

Prior to joining Yissum, Mr. Huberman was the Co-Founder of Artigon, served as part of the R&D team at Orgenics and as the Head of IP and R&D at MedisEl.

Tamir holds an MSc. in structural biology and a BSc. in biology from the Hebrew University, a diploma in computer & electronics and has continued his MBA studies at the Hebrew University. He is also a certified Trainer of NLP from ABNLP.

(LinkedIn Profile: http://il.linkedin.com/in/tamirhuberman/)
ITTN - Israel Tech Transfer Organization